img

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

There are commercial vaccines available containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. These vaccines are licensed in both breeding or growing pigs.
The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines include CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary, Ringpu Biology and Qilu Animal, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
By Type
Live Vaccines
Killed Vaccines
By Application
Government Tender
Market Sales
Sales by Region
North America
the United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
UK
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Definition
1.2 Market by Type
1.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Segment by Application
1.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales
2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region
2.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2018-2024)
2.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2024-2034)
2.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Region
2.6.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Manufacturers
3.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in 2022
3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers
3.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue in 2022
3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type
4.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type
4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type
4.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2018-2024)
4.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application
5.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application
5.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application
5.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2018-2024)
5.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Company
6.1.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2018-2024)
6.1.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
6.2.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2034)
6.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
6.3.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2034)
6.4 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
6.4.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2034)
6.4.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Country (2018-2034)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Company
7.1.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2018-2024)
7.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
7.2.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2034)
7.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
7.3.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2034)
7.4 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
7.4.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 UK
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Company
8.1.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2018-2024)
8.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
8.2.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2034)
8.3 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
8.3.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Company
9.1.1 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2018-2024)
9.2 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
9.2.1 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2034)
9.3 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
9.3.1 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2034)
9.4 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Region
9.4.1 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 CAHIC
11.1.1 CAHIC Company Information
11.1.2 CAHIC Overview
11.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.1.5 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
11.1.6 CAHIC Recent Developments
11.2 Merial
11.2.1 Merial Company Information
11.2.2 Merial Overview
11.2.3 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.2.5 Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
11.2.6 Merial Recent Developments
11.3 MSD Animal Health
11.3.1 MSD Animal Health Company Information
11.3.2 MSD Animal Health Overview
11.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.3.5 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
11.3.6 MSD Animal Health Recent Developments
11.4 Chopper Biology
11.4.1 Chopper Biology Company Information
11.4.2 Chopper Biology Overview
11.4.3 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.4.5 Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
11.4.6 Chopper Biology Recent Developments
11.5 Ceva
11.5.1 Ceva Company Information
11.5.2 Ceva Overview
11.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.5.5 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
11.5.6 Ceva Recent Developments
11.6 ChengDu Tecbond
11.6.1 ChengDu Tecbond Company Information
11.6.2 ChengDu Tecbond Overview
11.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.6.5 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
11.6.6 ChengDu Tecbond Recent Developments
11.7 Veterinary
11.7.1 Veterinary Company Information
11.7.2 Veterinary Overview
11.7.3 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.7.5 Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
11.7.6 Veterinary Recent Developments
11.8 Ringpu Biology
11.8.1 Ringpu Biology Company Information
11.8.2 Ringpu Biology Overview
11.8.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.8.5 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
11.8.6 Ringpu Biology Recent Developments
11.9 Qilu Animal
11.9.1 Qilu Animal Company Information
11.9.2 Qilu Animal Overview
11.9.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.9.5 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
11.9.6 Qilu Animal Recent Developments
11.10 DHN
11.10.1 DHN Company Information
11.10.2 DHN Overview
11.10.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.10.5 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
11.10.6 DHN Recent Developments
11.11 CAVAC
11.11.1 CAVAC Company Information
11.11.2 CAVAC Overview
11.11.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.11.5 CAVAC Recent Developments
11.12 Komipharm
11.12.1 Komipharm Company Information
11.12.2 Komipharm Overview
11.12.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.12.5 Komipharm Recent Developments
11.13 Agrovet
11.13.1 Agrovet Company Information
11.13.2 Agrovet Overview
11.13.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.13.5 Agrovet Recent Developments
11.14 Bioveta
11.14.1 Bioveta Company Information
11.14.2 Bioveta Overview
11.14.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.14.5 Bioveta Recent Developments
11.15 Jinyu Bio-Technology
11.15.1 Jinyu Bio-Technology Company Information
11.15.2 Jinyu Bio-Technology Overview
11.15.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.15.5 Jinyu Bio-Technology Recent Developments
11.16 Institutul Pasteur
11.16.1 Institutul Pasteur Company Information
11.16.2 Institutul Pasteur Overview
11.16.3 Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.16.5 Institutul Pasteur Recent Developments
11.17 MVP
11.17.1 MVP Company Information
11.17.2 MVP Overview
11.17.3 MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.17.4 MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.17.5 MVP Recent Developments
11.18 Tecon
11.18.1 Tecon Company Information
11.18.2 Tecon Overview
11.18.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.18.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.18.5 Tecon Recent Developments
11.19 Zoetis
11.19.1 Zoetis Company Information
11.19.2 Zoetis Overview
11.19.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.19.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products and Services
11.19.5 Zoetis Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Value Chain Analysis
12.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Mode & Process
12.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Marketing
12.4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Channels
12.4.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors
12.5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers
13 Market Dynamics
13.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
13.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
13.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
13.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2018-2024)
Table 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2024-2034)
Table 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2018-2024) & (K Units)
Table 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2018-2024)
Table 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2024-2034) & (K Units)
Table 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2024-2034)
Table 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Manufacturers (2018-2024)
Table 19. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Industry Ranking, 2021 VS 2022
Table 21. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines as of 2022)
Table 23. Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Share by Type (2018-2024)
Table 30. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Share by Type (2024-2034)
Table 31. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Type (2018-2024)
Table 34. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Type (2024-2034)
Table 35. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Share by Application (2018-2024)
Table 40. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Share by Application (2024-2034)
Table 41. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Application (2018-2024)
Table 44. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Application (2024-2034)
Table 45. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 117. CAHIC Company Information
Table 118. CAHIC Description and Overview
Table 119. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 121. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
Table 122. CAHIC Recent Developments
Table 123. Merial Company Information
Table 124. Merial Description and Overview
Table 125. Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 127. Merial Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
Table 128. Merial Recent Developments
Table 129. MSD Animal Health Company Information
Table 130. MSD Animal Health Description and Overview
Table 131. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 133. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
Table 134. MSD Animal Health Recent Developments
Table 135. Chopper Biology Company Information
Table 136. Chopper Biology Description and Overview
Table 137. Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 138. Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 139. Chopper Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
Table 140. Chopper Biology Recent Developments
Table 141. Ceva Company Information
Table 142. Ceva Description and Overview
Table 143. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 144. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 145. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
Table 146. Ceva Recent Developments
Table 147. ChengDu Tecbond Company Information
Table 148. ChengDu Tecbond Description and Overview
Table 149. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 150. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 151. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
Table 152. ChengDu Tecbond Recent Developments
Table 153. Veterinary Company Information
Table 154. Veterinary Description and Overview
Table 155. Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 156. Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 157. Veterinary Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
Table 158. Veterinary Recent Developments
Table 159. Ringpu Biology Company Information
Table 160. Ringpu Biology Description and Overview
Table 161. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 162. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 163. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
Table 164. Ringpu Biology Recent Developments
Table 165. Qilu Animal Company Information
Table 166. Qilu Animal Description and Overview
Table 167. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 168. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 169. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
Table 170. Qilu Animal Recent Developments
Table 171. DHN Company Information
Table 172. DHN Description and Overview
Table 173. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 174. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 175. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines SWOT Analysis
Table 176. DHN Recent Developments
Table 177. CAVAC Company Information
Table 178. CAVAC Description and Overview
Table 179. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 180. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 181. CAVAC Recent Developments
Table 182. Komipharm Company Information
Table 183. Komipharm Description and Overview
Table 184. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 185. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 186. Komipharm Recent Developments
Table 187. Agrovet Company Information
Table 188. Agrovet Description and Overview
Table 189. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 190. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 191. Agrovet Recent Developments
Table 192. Bioveta Company Information
Table 193. Bioveta Description and Overview
Table 194. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 195. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 196. Bioveta Recent Developments
Table 197. Jinyu Bio-Technology Company Information
Table 198. Jinyu Bio-Technology Description and Overview
Table 199. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 200. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 201. Jinyu Bio-Technology Recent Developments
Table 202. Institutul Pasteur Company Information
Table 203. Institutul Pasteur Description and Overview
Table 204. Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 205. Institutul Pasteur Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 206. Institutul Pasteur Recent Developments
Table 207. MVP Company Information
Table 208. MVP Description and Overview
Table 209. MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 210. MVP Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 211. MVP Recent Developments
Table 212. Tecon Company Information
Table 213. Tecon Description and Overview
Table 214. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 215. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 216. Tecon Recent Developments
Table 217. Zoetis Company Information
Table 218. Zoetis Description and Overview
Table 219. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 220. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product and Services
Table 221. Zoetis Recent Developments
Table 222. Key Raw Materials Lists
Table 223. Raw Materials Key Suppliers Lists
Table 224. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List
Table 225. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers List
Table 226. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Trends
Table 227. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
Table 228. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
Table 229. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
Table 230. Research Programs/Design for This Report
Table 231. Key Data Information from Secondary Sources
Table 232. Key Data Information from Primary Sources
List of Figures
Figure 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Picture
Figure 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Type in 2022 & 2034
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Application in 2022 & 2034
Figure 8. Government Tender
Figure 9. Market Sales
Figure 10. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Report Years Considered
Figure 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue 2018-2034 (US$ Million)
Figure 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity 2018-2034 (K Units)
Figure 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 18. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. APAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity in 2022
Figure 28. The Top 10 and Top 5 Players Market Share by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue in 2022
Figure 29. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2018-2034)
Figure 32. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2018-2034)
Figure 34. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Company in 2022
Figure 35. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Market Share by Company in 2022
Figure 36. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2018-2034)
Figure 38. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2018-2034)
Figure 40. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Country (2018-2034)
Figure 41. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Share by Country (2018-2034)
Figure 42. the United States Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Quantity Market Share by Company in 2022
Figure 45. Europe Porcine Repr

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries